BrightSpring Short Long Term Debt Total from 2010 to 2025
| BTSG Stock | 17.45 0.03 0.17% |
Short and Long Term Debt Total | First Reported 2010-12-31 | Previous Quarter 343.1 M | Current Value 326 M | Quarterly Volatility 965.2 M |
Check BrightSpring Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BrightSpring Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 192.9 M, Interest Expense of 209.4 M or Total Revenue of 7.4 B, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 1.38. BrightSpring financial statements analysis is a perfect complement when working with BrightSpring Health Valuation or Volatility modules.
BrightSpring | Short Long Term Debt Total |
Latest BrightSpring Health's Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of BrightSpring Health Services, over the last few years. It is BrightSpring Health's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BrightSpring Health's overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
BrightSpring Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 2,450,032,288 | |
| Geometric Mean | 2,086,051,365 | |
| Coefficient Of Variation | 39.40 | |
| Mean Deviation | 537,044,606 | |
| Median | 2,443,497,000 | |
| Standard Deviation | 965,230,616 | |
| Sample Variance | 931670.1T | |
| Range | 3.4B | |
| R-Value | (0.16) | |
| Mean Square Error | 971655.6T | |
| R-Squared | 0.03 | |
| Significance | 0.55 | |
| Slope | (33,071,828) | |
| Total Sum of Squares | 13975052.1T |
BrightSpring Short Long Term Debt Total History
About BrightSpring Health Financial Statements
BrightSpring Health stakeholders use historical fundamental indicators, such as BrightSpring Health's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although BrightSpring Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in BrightSpring Health's assets and liabilities are reflected in the revenues and expenses on BrightSpring Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BrightSpring Health Services,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 343.1 M | 326 M |
Currently Active Assets on Macroaxis
When determining whether BrightSpring Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if BrightSpring Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Brightspring Health Services, Stock. Highlighted below are key reports to facilitate an investment decision about Brightspring Health Services, Stock:Check out the analysis of BrightSpring Health Correlation against competitors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BrightSpring Health. If investors know BrightSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BrightSpring Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.333 | Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth 0.286 | Return On Assets |
The market value of BrightSpring Health is measured differently than its book value, which is the value of BrightSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BrightSpring Health's value that differs from its market value or its book value, called intrinsic value, which is BrightSpring Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BrightSpring Health's market value can be influenced by many factors that don't directly affect BrightSpring Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BrightSpring Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrightSpring Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrightSpring Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.